These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37842091)

  • 1. ICOSLG-associated immunological landscape and diagnostic value in oral squamous cell carcinoma: a prospective cohort study.
    Dong Y; Hu X; Xie S; Song Y; He Y; Jin W; Ni Y; Wang Z; Ding L
    Front Cell Dev Biol; 2023; 11():1257314. PubMed ID: 37842091
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamous cell carcinoma.
    Hu X; Dong Y; Xie S; Song Y; Yu C; He Y; Wang Z; Hu Q; Ni Y; Ding L
    J Pathol Clin Res; 2024 Mar; 10(2):e353. PubMed ID: 38502058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICOS/ICOSLG and PD-1 Co-Expression is Associated with the Progression of Colorectal Precancerous- Carcinoma Immune Microenvironment.
    Zhang Y; Wang XL; Liu JJ; Qian ZY; Pan ZY; Song NP; Chen HY; Zhang W; Zhang X
    J Inflamm Res; 2023; 16():977-992. PubMed ID: 36915615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint.
    Ding Z; He Y; Fu Y; Zhu N; Zhao M; Song Y; Huang X; Chen S; Yang Y; Zhang C; Hu Q; Ni Y; Ding L
    Front Oncol; 2021; 11():687430. PubMed ID: 34211854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas.
    Chang SR; Chou CH; Liu CJ; Lin YC; Tu HF; Chang KW; Lin SC
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid Droplet-Related PLIN2 in CD68
    He Y; Dong Y; Zhang X; Ding Z; Song Y; Huang X; Chen S; Wang Z; Ni Y; Ding L
    Front Oncol; 2022; 12():824235. PubMed ID: 35372038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Heterogeneity of Reelin in the Oral Squamous Cell Carcinoma Microenvironment.
    Zhang X; Fu Y; Ding Z; Zhu N; Zhao M; Song Y; Huang X; Chen S; Yang Y; Zhang C; Hu Q; Ni Y; Ding L
    Front Oncol; 2021; 11():692390. PubMed ID: 34485127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma.
    Cho YA; Yoon HJ; Lee JI; Hong SP; Hong SD
    Oral Oncol; 2011 Dec; 47(12):1148-53. PubMed ID: 21911310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating ICOS
    Kajikawa H; Hirata M; Haruna M; Ueyama A; Hirose K; Kawashima A; Iwahori K; Matsunaga K; Toyosawa S; Uzawa N; Wada H
    Anticancer Res; 2022 May; 42(5):2383-2393. PubMed ID: 35489733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
    Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
    BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.
    Foy JP; Bertolus C; Michallet MC; Deneuve S; Incitti R; Bendriss-Vermare N; Albaret MA; Ortiz-Cuaran S; Thomas E; Colombe A; Py C; Gadot N; Michot JP; Fayette J; Viari A; Van den Eynde B; Goudot P; Devouassoux-Shisheboran M; Puisieux A; Caux C; Zrounba P; Lantuejoul S; Saintigny P
    Ann Oncol; 2017 Aug; 28(8):1934-1941. PubMed ID: 28460011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 Expression in Head and Neck Squamous Cell Carcinomas Derives Primarily from Functionally Anergic CD4
    Mattox AK; Lee J; Westra WH; Pierce RH; Ghossein R; Faquin WC; Diefenbach TJ; Morris LG; Lin DT; Wirth LJ; Lefranc-Torres A; Ishida E; Chakravarty PD; Johnson L; Zeng YC; Chen H; Poznansky MC; Iyengar NM; Pai SI
    Cancer Res; 2017 Nov; 77(22):6365-6374. PubMed ID: 28947422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoexpression of PD-L1, CD4+ and CD8+ cell infiltrates and tumor-infiltrating lymphocytes (TILs) in the microenvironment of actinic cheilitis and lower lip squamous cell carcinoma.
    Souza VG; Santos DJS; Silva AG; Ribeiro RIMA; Loyola AM; Cardoso SV; Miranda CSS; Cardoso LPV
    J Appl Oral Sci; 2022; 30():e20210344. PubMed ID: 35195152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
    Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
    Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
    Ma SR; Liu JF; Jia R; Deng WW; Jia J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
    Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
    Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma.
    Ahn H; Yang JM; Kim H; Chung JH; Ahn SH; Jeong WJ; Paik JH
    Oncotarget; 2017 Sep; 8(39):66178-66194. PubMed ID: 29029502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.